文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

COVID-19疫情前后住院老年人谵妄及新型抗精神病药和苯二氮䓬类药物使用趋势

Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic.
PubMed 文献 · JAMA Netw Open · 2023-08-01
一句话结论安大略省住院老年人数据显示,COVID-19疫情开始后谵妄率及出院后新型抗精神病药、苯二氮䓬类处方率显著升高,并持续2年。

该基于人群的重复横断面研究利用关联数据库,纳入加拿大安大略省2017年1月1日至2022年3月31日期间66岁及以上住院老年人,比较疫情前3年模型预测率与疫情开始后2年(2020年3月1日至2022年3月31日)观察到的谵妄率及新型抗精神病药、苯二氮䓬类处方率。共纳入2 128 411例次住院(女性50.7%,平均年龄78.9岁)。谵妄绝对率从疫情前的35.9/1000入院人口升至疫情全期的41.5/1000入院人口,校正率比(ARR)为1.15(95%CI 1.11-1.19)。新型抗精神病药月处方率从6.9升至8.8/1000出院人口(ARR 1.28,95%CI 1.19-1.38),新型苯二氮䓬类从4.4升至6.0/1000出院人口(ARR 1.37,95%CI 1.20-1.57)。疫情第1、3、5波期间率最高,且整个2年期间持续高于预测水平。

要点

  • 疫情开始后住院老年人谵妄率从35.9/1000入院人口升至41.5/1000入院人口,校正率比1.15(95%CI 1.11-1.19)。
  • 出院后新型抗精神病药月处方率从6.9升至8.8/1000出院人口,校正率比1.28(95%CI 1.19-1.38)。
  • 出院后新型苯二氮䓬类月处方率从4.4升至6.0/1000出院人口,校正率比1.37(95%CI 1.20-1.57)。
  • 疫情第1波(2020年3-6月)、第3波(2021年3-6月)和第5波(2021年12月至2022年2月)期间率最高,且2年内持续高于预测水平。
  • 作者认为探视限制、人员短缺、隔离措施及床旁工作人员时间减少可能促成了上述趋势。

适用人群与场景

  • 加拿大安大略省66岁及以上住院老年人,研究期间2017年1月1日至2022年3月31日,共2 128 411例次住院(女性50.7%,平均年龄78.9岁,SD 8.3岁)。

研究设计与关键结果

  • 研究类型:基于人群的重复横断面研究,利用关联数据库,比较疫情前3年模型预测率与疫情开始后2年(2020年3月1日至2022年3月31日)观察率。
  • 主要终点:谵妄绝对率从疫情前的35.9/1000入院人口升至疫情全期的41.5/1000入院人口,校正率比(ARR)1.15(95%CI 1.11-1.19)。
  • 关键次要终点:新型抗精神病药月处方率从6.9升至8.8/1000出院人口(ARR 1.28,95%CI 1.19-1.38);新型苯二氮䓬类月处方率从4.4升至6.0/1000出院人口(ARR 1.37,95%CI 1.20-1.57)。
  • 率在疫情第1波(2020年3-6月)、第3波(2021年3-6月)和第5波(2021年12月至2022年2月)最高,且整个疫情前2年持续高于预测水平。

证据类型、等级与局限

  • 证据类型:基于人群的重复横断面研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,疫情相关的探视限制、人员短缺、隔离措施及床旁工作人员时间减少可能促成了谵妄率及出院后新型抗精神病药和苯二氮䓬类处方率的升高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The COVID-19 pandemic caused large disruptions to health care for hospitalized older adults. The incidence and management of delirium may have been affected by high rates of COVID-19 infection, staffing shortages, overwhelmed hospital capacity, and changes to visitor policies.

OBJECTIVE: To measure changes in rates of delirium and related medication prescribing during the COVID-19 pandemic among hospitalized older adults.

DESIGN, SETTING, AND PARTICIPANTS: This population-based, repeated cross-sectional study used linked databases to measure rates of delirium and related medication prescriptions among adults aged 66 years or older hospitalized before and during the COVID-19 pandemic (January 1, 2017, to March 31, 2022) in Ontario, Canada.

EXPOSURE: The first 2 years of the COVID-19 pandemic (March 1, 2020, to March 31, 2022).

MAIN OUTCOMES AND MEASURES: The main outcomes were weekly rates of delirium per 1000 admitted population and monthly rates of new antipsychotic and benzodiazepine prescriptions per 1000 discharged population. Observed rates were compared with projected rates based on modeling from 3 years before pandemic onset.

RESULTS: Among 2 128 411 hospitalizations of older adults over the 5-year study period (50.7% female; mean [SD] age, 78.9 [8.3] years), absolute rates of delirium increased from 35.9 per 1000 admitted population during the prepandemic period to 41.5 per 1000 admitted population throughout the pandemic. The adjusted rate ratio (ARR) of delirium during the pandemic compared with the projected rate was 1.15 (95% CI, 1.11-1.19). Monthly rates of new antipsychotic prescriptions increased from 6.9 to 8.8 per 1000 discharged population and new benzodiazepine prescriptions from 4.4 to 6.0 per 1000 discharged population and were significantly higher during the pandemic compared with projected rates (antipsychotics: ARR, 1.28; 95% CI, 1.19-1.38; benzodiazepines: ARR, 1.37; 95% CI, 1.20-1.57). Rates were highest during pandemic waves 1 (March to June 2020), 3 (March to June 2021), and 5 (December 2021 to February 2022) and remained elevated above projected levels throughout the first 2 years of the pandemic.

CONCLUSIONS AND RELEVANCE: In this repeated cross-sectional study of hospitalized older adults, there was a temporal association between COVID-19 pandemic onset and significant increases in rates of delirium in the hospital and new antipsychotic and benzodiazepine prescriptions after hospital discharge. Rates remained elevated over 2 years. Pandemic-related changes such as visitor restrictions, staff shortages, isolation practices, and reduced staff time at the bedside may have contributed to these trends.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Reppas-Rindlisbacher C, Boblitz A, Fowler RA, et al. Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic. JAMA Netw Open. 2023. PMID: 37548976. doi:10.1001/jamanetworkopen.2023.27750

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。